In the Valsartan in Acute Myocardial Infarction Trial (VALIANT), hypotension in post-myocardial infarction patients led to permanent discontinuation of therapy in 1.4% of valsartan-treated patients and 0.8% of captopril-treated patients
PrymaLab supplies PT-141 (bremelanotide) as a preloaded 3ml autoinjector pen at 10mg/ml, research-use-only, with transparent sourcing and batch traceability
Tesamorelin has the most robust evidence base , anchored by FDA approval and Phase 3 randomised controlled trials, particularly for visceral fat reduction
Studies, such as those published in Cell Metabolism, suggest that GLP-1 can dampen this reward response, making these foods seem less appealing and reducing cravings
SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential
This week on the You Are Not Broken podcast episode #329, I sat down with the powerhouse that is Dr